Pupillographic, tonographic and refractive parameter changes after topical instillation of Brimonidine tartrate 0.2% in healthy subjects.
Brogliatti
B
B
Eye Clinic, University of Turin.
Bogetto
C
C
Prandi
B
B
Boles Carenini
B
B
D000065:Accommodation, Ocular / Q000187:drug effects; D000287:Administration, Topical; D000316:Adrenergic alpha-Agonists / Q000008:administration & dosage*; D000328:Adult; D001082:Aqueous Humor / Q000187:drug effects; D000068438:Brimonidine Tartrate; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects*; D008297:Male; D011680:Pupil / Q000187:drug effects*; D011810:Quinoxalines / Q000008:administration & dosage*; D012016:Reference Values; D012029:Refraction, Ocular / Q000187:drug effects*; D014065:Tonometry, Ocular